Loading stock data...
Exact Sciences Corporation (EXAS) Stock Price, Chart & Analysis
Exact Sciences CorporationEXAS
Market Closed$47.76
+$0.81+1.73%
EXAS Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for EXAS to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Exact Sciences Corporation (EXAS)
Loading chart data...
Is Exact Sciences Corporation (EXAS) Stock a Buy in 2025?
YES
STRONG BUY
Score: 90/100
Yes, EXAS stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether EXAS stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong revenue growth of 10.4%
- Healthcare sector momentum
- Mid-cap growth potential
Valuation Considerations
- Analyst price targets suggest 43.5% upside potential
Risk Factors
- High debt-to-equity ratio of 105.93
- Healthcare sector cyclicality
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$68.55
Upside Potential:43.5%
Investment Summary
EXAS presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 10.4%, though analyst price targets suggest 43.5% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 105.93, and consider their own risk tolerance and investment timeline.
Final Recommendation
STRONG BUY
Recommendation Score
Overall Score:90/100
Strong Buy
2030 Price Prediction
Predicted Price:$68.98
Potential Return:+44.4%
Key Factors
- Strong revenue growth
- Very strong analyst buy consensus
- Significant upside potential
- Moderate long-term growth potential to 2030
- Extremely high debt levels
- Debt-to-Market-Cap Ratio: 28.2% (Healthy)
Investment Decision
Based on our comprehensive analysis of EXAS's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
exas Stock Price Prediction 2030
Predicted 2030 Price
$68.98
+44.4%from current price
Based on revenue growth analysis and market trends, exas stock is projected to reach $68.98 by 2030, representing a 44.4% increase from the current price of $47.76.
Current Price
$47.76
Revenue Growth
10.9%
Analyst Target
$68.55
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in exas Stock?
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
4. Investment Decision
Make buy/hold/sell decision with price targets
Company Profile
Exact Sciences Corporation
Healthcare
Diagnostics & Research
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect...
Employees
6,900
Market Cap
$9.01B